Latent Iron Deficiency

Also known as: Iron Deficiency, Latent / Iron deficiency / Iron Deficiencies / Iron deficiency (disorder)

Drug	Drug Name	Drug Description
DB13257	Ferrous sulfate anhydrous	An iron supplement used to prevent or treat iron deficiency anemia.
DB00158	Folic acid	A nutrient used to treat megaloblastic anemia and is found in many supplements.

Drug	Drug Name	Target	Type
DB13257	Ferrous sulfate anhydrous	Natural resistance-associated macrophage protein 2	transporter
DB13257	Ferrous sulfate anhydrous	Ceruloplasmin	enzyme
DB13257	Ferrous sulfate anhydrous	Hemoglobin subunit alpha	target
DB13257	Ferrous sulfate anhydrous	Transferrin receptor	target
DB13257	Ferrous sulfate anhydrous	Solute carrier family 40 member 1	transporter
DB13257	Ferrous sulfate anhydrous	Hepcidin	enzyme
DB13257	Ferrous sulfate anhydrous	Serotransferrin	enzyme
DB13257	Ferrous sulfate anhydrous	Hephaestin	enzyme
DB13257	Ferrous sulfate anhydrous	Cytochrome b reductase 1	enzyme
DB00158	Folic acid	Folate receptor gamma	target
DB00158	Folic acid	Folate receptor beta	target
DB00158	Folic acid	Methylenetetrahydrofolate reductase	enzyme
DB00158	Folic acid	Multidrug resistance-associated protein 4	transporter
DB00158	Folic acid	Solute carrier family 22 member 6	transporter
DB00158	Folic acid	Canalicular multispecific organic anion transporter 2	transporter
DB00158	Folic acid	ATP-binding cassette sub-family C member 11	transporter
DB00158	Folic acid	ATP-binding cassette sub-family G member 2	transporter
DB00158	Folic acid	Proton-coupled folate transporter	transporter
DB00158	Folic acid	Mitochondrial folate transporter/carrier	transporter
DB00158	Folic acid	Gamma-glutamyl hydrolase	enzyme
DB00158	Folic acid	Folate receptor alpha	target
DB00158	Folic acid	Dihydrofolate reductase	enzyme

Drug	Drug Name	Phase	Status	Count
DB08917	Ferric carboxymaltose	4	Recruiting	1
DB15763	Iron polymaltose	4	Recruiting	1
DB13257	Ferrous sulfate anhydrous	Not Available	Suspended	1